Immunogenicity and Safety Study of Different Formulations of GlaxoSmithKline (GSK) Biologicals H7N1 Influenza Vaccine Administered to Adults 65 Years of Age and Older
Clinical trial NCT01949090 · COMPLETED
Trial details
- NCT number
- NCT01949090
- Sponsor
- GlaxoSmithKline
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2013-09-25
- Primary completion
- 2013-12-04
- Enrollment
- 363
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.